Authors
Latest:
New Treatment Options Are on the Horizon for β-ThalassemiaGene therapies in late-stage development may soon provide hope for a cure.
Latest:
Helping Pharmacists Excel in the ‘New Normal’With more work and less staff, we need to examine how we can better support pharmacists in the new normal brought on by COVID-19.
Latest:
Securing the Supply Chain: The DSCSA and the New Importation Policy in FloridaIn January 2024, Florida became the only state to allow the importation of medications for public use.
Latest:
Considerations for Environmentally Conscious Pharmacy StudentsEnvironmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Latest:
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood CancerAdvances, challenges, and promising innovations emerge.
Latest:
The Role of Medicinal Plants in Modern PharmacyResearchers are working to solve consistency and ecological and ethical concerns in pharmaceutical formulations
Latest:
Recognize the Value of Health Care VolunteersThe health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Latest:
Interprofessional Education in Medical School Creates a Collaborative EnvironmentAdaptability, teamwork, and a culture of lifetime learning are required virtues in our rapidly evolving medical landscape.
Latest:
Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path AheadHigh-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
Latest:
The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AIAI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.
Latest:
It Is Time to Consider Alternatives to Discipline ProgramsProfessional assistance programs provide pathway for health care professionals to return to practice following treatment for substance use disorder.
Latest:
What Drug Rates Are Reported in Price Transparency Data?It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.
Latest:
Understanding Pharmacogenomics Is Essential for Personalized CarePharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
Latest:
Bacteroidetes: The Jekyll and Hyde of the Human Gut MicrobiomeThe relative abundance of gram-negative Bacteroidetes to other phyla, such as gram-positive Firmicutes, is essential to maintain biodiversity and human gut health.
Latest:
Therapies Under Investigation for Waldenström MacroglobulinemiaThe exciting therapies in the pipeline that are thought to target novel mechanisms in Waldenström macroglobulinemia.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Latest:
Insights on the UK's MHRA International Recognition ProcedureThe UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Latest:
New Frontiers in Technology: AI Use in Clinical Trial Patient Recruitment in Health SystemsAI is significantly enhancing the efficiency of identifying and enrolling patients.
Latest:
Long Story Short: Cellulitis Can Be Treated in Less Than a WeekDuration of therapy may be just 5 to 6 days for patients without risk factors for complications.
Latest:
One Year Later: Key Issues Impacting Health System Pharmacies During the COVID-19 Vaccine RolloutThis vaccine rollout has become even more crucial for the US health care system, as new mutations of the coronavirus continue to emerge.
Latest:
How Data Can Help Demonstrate the Value of the Health-System Specialty PharmacyInsurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.
Latest:
As Shortages Continue, Suppliers, Hospitals, and Health Systems Look for New SolutionsHospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.
Latest:
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy SettingsAlthough pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Latest:
Integration of Palliative Pharmacists to Elevate Oncologic CarePalliative pharmacists are invaluable assets of oncologic care.
Latest:
Impact of Tardive Dyskinesia on Quality of LifePanelists discuss how untreated tardive dyskinesia severely impacts patients' daily functioning and quality of life through physical limitations affecting basic tasks like eating and walking, social isolation due to visible symptoms, and heightened risks for older adults who face increased fall risks, difficulty maintaining independence, and complications from age-related comorbidities.
Latest:
Interaction Considerations for Common OTC Drug ClassesAlthough OTC medications are generally considered safe when used as directed, there are some key drug interactions for pharmacists to keep in mind when helping patients choose an OTC product.
Latest:
Pharmacists Have a Significant Role in the Prevention of Travel-Related DiseasesWhen helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.
